0000950170-24-025885.txt : 20240305 0000950170-24-025885.hdr.sgml : 20240305 20240305160758 ACCESSION NUMBER: 0000950170-24-025885 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240305 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240305 DATE AS OF CHANGE: 20240305 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Marpai, Inc. CENTRAL INDEX KEY: 0001844392 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40904 FILM NUMBER: 24720348 BUSINESS ADDRESS: STREET 1: 615 CHANNELSIDE DRIVE STREET 2: SUITE 207 CITY: TAMPA STATE: FL ZIP: 33602 BUSINESS PHONE: 646-303-3483 MAIL ADDRESS: STREET 1: 615 CHANNELSIDE DRIVE STREET 2: SUITE 207 CITY: TAMPA STATE: FL ZIP: 33602 8-K 1 mrai-20240305.htm 8-K 8-K
false000184439200018443922024-03-052024-03-05

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 05, 2024

 

 

MARPAI, INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-40904

86-1916231

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

615 Channelside Drive, Suite 207

 

Tampa, Florida

 

33602

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 646 303-3483

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Class A Common Stock, par value $0.0001 per share

 

MRAI

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


Item 8.01 Other Events.

On March 5, 2024, Marpai, Inc. issued a press release titled, “Marpai Announces Off-Cycle New Client Agreement”. A copy of the press release is attached as Exhibit 99.1 hereto and is incorporated by reference herein.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit
Number

Description

99.1

 

Press Release, dated March 5, 2024

104

Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

MARPAI, INC.

 

 

 

 

Date:

March 5, 2024

By:

/s/ Damien Lamendola

 

 

 

Name: Damien Lamendola
Title: Chief Executive Officer

 


EX-99.1 2 mrai-ex99_1.htm EX-99.1 EX-99.1

EXH 99.1

FOR IMMEDIATE RELEASEimg155121336_0.jpg

 

 

MARPAI ANNOUNCES “Off-cycle” new client agreement

 

Marpai executes new client agreement furthering its expansion in the Southeast.

Tampa, March 5, 2024, Marpai, Inc. (“Marpai” or the “Company”) (Nasdaq: MRAI), an independent national Third-Party Administration (“TPA”) company transforming the $22 billion TPA market supporting self-funded employer health plans with affordable, intelligent, healthcare, today announced that it has signed a three-year agreement to provide healthcare benefit services to a regional organization based in the southeast.

 

The agreement commenced this month, and it is expected to bring at least 20,000 households by the end of 2024.

 

John Powers, Marpai’s President, commented, “We are very pleased to bring on a new client, especially off the normal calendar year cycle of benefit plan contracts. Marpai’s custom solution and ability to move quickly to service the client, while offering significant cost savings, was crucial in Marpai winning the new business. We believe thar our vision of providing affordable healthcare and solid member experience is resonating with the market as companies continue to struggle with inflationary pressures.”

 

 

About Marpai, Inc.

 

Marpai, Inc. (Nasdaq: MRAI) is a leading, national TPA company bringing value-oriented health plan services to employers that directly pay for employee health benefits. Primarily competing in the $22 billion TPA sector serving self-funded employer health plans representing over $1 trillion in annual claims. Marpai works to deliver the healthiest member population for the health plan budget. Operating nationwide, Marpai offers access to leading provider networks including Aetna and Cigna and all TPA services. For more information, visit www.marpaihealth.com, the content of which is not incorporated by reference into this press release.

Forward-Looking Statement Disclaimer


This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," “guidance,” "may," "can," "could", "will", "potential", "should," "goal" and variations of these words or similar expressions. For example, the Company is using forward looking statements when it discusses the number of expected households being brought pursuant to the agreement by the end of 2024 and the belief that its vision of providing affordable healthcare and solid member experience is resonating with the market as companies continue to struggle with inflationary pressures. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect Marpai's current expectations and speak only as of the date of this release. Actual results may differ materially from Marpai's current expectations depending upon a number of factors. These factors include, among others, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business. Except as required by law, Marpai does not undertake any responsibility to revise or update any forward-looking statements whether as a result of new information, future events or otherwise.


EXH 99.1

More detailed information about Marpai and the risk factors that may affect the realization of forward-looking statements is set forth in Marpai's filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov.

 

Investor Relations contact:
Steve Johnson

steve.johnson@marpaihealth.com

###


GRAPHIC 3 img155121336_0.jpg GRAPHIC begin 644 img155121336_0.jpg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end EX-101.SCH 4 mrai-20240305.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink Cover [Abstract] Amendment Flag City Area Code Document Period End Date Document Type Entity Address, Address Line One Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province Entity Central Index Key Entity Emerging Growth Company Entity Ex Transition Period Entity File Number Entity Incorporation, State or Country Code Entity Registrant Name Entity Tax Identification Number Local Phone Number Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Title of 12(b) Security Security Exchange Name Soliciting Material Trading Symbol Written Communications XML 5 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Document And Entity Information
Mar. 05, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 05, 2024
Entity Registrant Name MARPAI, INC.
Entity Central Index Key 0001844392
Entity Emerging Growth Company true
Entity File Number 001-40904
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 86-1916231
Entity Address, Address Line One 615 Channelside Drive, Suite 207
Entity Address, City or Town Tampa
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33602
City Area Code 646
Local Phone Number 303-3483
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Ex Transition Period true
Title of 12(b) Security Class A Common Stock, par value $0.0001 per share
Trading Symbol MRAI
Security Exchange Name NASDAQ
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://www.marpaihealth.com/20240305/taxonomy/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports mrai-20240305.htm mrai-20240305.xsd http://xbrl.sec.gov/dei/2023 false false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "mrai-20240305.htm": { "nsprefix": "mrai", "nsuri": "http://www.marpaihealth.com/20240305", "dts": { "inline": { "local": [ "mrai-20240305.htm" ] }, "schema": { "local": [ "mrai-20240305.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://www.marpaihealth.com/20240305/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_c14a9e1f-4e01-43c8-8d10-92f2b0763572", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "mrai-20240305.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_c14a9e1f-4e01-43c8-8d10-92f2b0763572", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "mrai-20240305.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.marpaihealth.com/20240305/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.marpaihealth.com/20240305/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.marpaihealth.com/20240305/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.marpaihealth.com/20240305/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.marpaihealth.com/20240305/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.marpaihealth.com/20240305/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.marpaihealth.com/20240305/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.marpaihealth.com/20240305/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.marpaihealth.com/20240305/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.marpaihealth.com/20240305/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://www.marpaihealth.com/20240305/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.marpaihealth.com/20240305/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.marpaihealth.com/20240305/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.marpaihealth.com/20240305/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.marpaihealth.com/20240305/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.marpaihealth.com/20240305/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.marpaihealth.com/20240305/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.marpaihealth.com/20240305/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.marpaihealth.com/20240305/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.marpaihealth.com/20240305/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.marpaihealth.com/20240305/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.marpaihealth.com/20240305/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.marpaihealth.com/20240305/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 14 0000950170-24-025885-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-025885-xbrl.zip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end XML 15 mrai-20240305_htm.xml IDEA: XBRL DOCUMENT 0001844392 2024-03-05 2024-03-05 false 0001844392 8-K 2024-03-05 MARPAI, INC. DE 001-40904 86-1916231 615 Channelside Drive, Suite 207 Tampa FL 33602 646 303-3483 false false false false Class A Common Stock, par value $0.0001 per share MRAI NASDAQ true true